Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized placebo-controlled phase III trial of Vagantin (methanthelinium bromide) for focal palmar-axillary hyperhidrosis
2007-007055-13Phase 3Completed
- Sponsor
- RIEMSER
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Primary hyperhidrosis (PH) comparing Vagantin with Placebo (2 arms). Primary endpoint: Primary: axillary sweat gravimetry at day 28 ±1 day. Started Nov 2008; status: completed.
02
Drugs
methantheline
03
Conditions
Primary hyperhidrosis (PH)
Beyond the preview
Go deeper on 2007-007055-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007055-13.